Similarly, it is possible that some cases classified as IDH-wild type (glioblastoma) should have been categorized as astrocytomas since only IDH-1 mutations were evaluated and IDH-2 mutations were not assessed. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).